Health
100 Most Popular
Therapy

CRISPR

$49.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.74 (1.53%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CRISPR and other stocks, options, ETFs, and crypto commission-free!

About CRSP

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. Read More The company was founded by Rodger Novak, Emmanuelle Charpentier, and Shaun Patrick Foy in 2014 and is headquartered in Zug, Switzerland.

Employees
188
Headquarters
Zug, Zug
Founded
2014
Market Cap
2.55B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
379.92K
High Today
$49.61
Low Today
$48.03
Open Price
$48.56
Volume
421.65K
52 Week High
$61.97
52 Week Low
$22.22

Collections

Health
100 Most Popular
Therapy
Biotechnology
Medical
Technology
2016 IPO

CRSP News

BenzingaJun 26

ERS Genomics Provides Comment on New Patent Interference With the Broad Institute Relating to Invention of the CRISPR/Cas9 System

2,177

CRSP Earnings

-$1.07
-$0.71
-$0.36
$0.00
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 29, After Hours

Popular Stocks

More CRSP News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.